Institute of Chemistry, University of Sao Paulo (USP), Sao Paulo, SP, Brazil.
Department of Pharmaceutical Sciences, Federal University of Sao Paulo (UNIFESP), Diadema, SP, Brazil.
J Chromatogr A. 2019 Jan 4;1583:136-142. doi: 10.1016/j.chroma.2018.10.005. Epub 2018 Nov 2.
A capillary electrophoresis with diode array and tandem mass spectrometry detection (CE-UV-MS/MS) method has been developed for the targeted assessment of cardiovascular biomarkers candidates, trimethylamine-N-Oxide (TMAO) and l-carnitine, and creatinine in human urine samples. The dual detection was applied due to the high concentration of creatinine (monitored by UV detection at 200 nm) in relation to TMAO and l-carnitine (quantified by selected reaction monitoring (SRM) mass spectrometry), in human urine. All instrumental parameters, sheath liquid (SHL) and background electrolyte (BGE) compositions were optimized with a pool of urine provided by adult healthy volunteers and evaluated by signal-to-noise ratio (SNR) and peak shape of TMAO. The compositions for the optimized BGE was formic acid at concentration of 0.10 mol L, and for SHL was 70:30 MeOH:HO containing 0.05% (v/v) formic acid, delivered at a flow rate of 5 μL min. Limits of detection for TMAO, l-carnitine and creatinine were 0.76, 0.54 and 303 μmol L, respectively. Limits of quantification were 2.5, 1.8 and 1000 μmol L, respectively. Linearity was evaluated by ANOVA and presented R from 0.993 to 0.997. Precision and accuracy were evaluated at three concentration levels. Coefficients of variation (CV) from 1 to 21% were obtained for the intra-day precision evaluation and from 2 to 16% for the inter-day precision evaluation. The recovery ranged from 75 to 116%. Quantitation of TMAO and l-carnitine in infarcted patients urine in comparison to healthy individuals indicated a 2.2 fold increase of TMAO and a 7.0 fold increase of l-carnitine. These results showed the potential applicability of the proposed method for the evaluation of TMAO and l-carnitine in urine within a panel of candidate metabolites in targeted metabolomics studies of cardiovascular diseases among other conditions.
已开发出一种采用二极管阵列和串联质谱检测的毛细管电泳法(CE-UV-MS/MS),用于靶向评估人尿液样本中的心血管生物标志物候选物——氧化三甲胺(TMAO)、左旋肉碱和肌酐。由于人尿液中肌酐浓度较高(通过200 nm处的紫外检测监测),而TMAO和左旋肉碱浓度较低(通过选择反应监测(SRM)质谱法定量),因此采用了双重检测。所有仪器参数、鞘液(SHL)和背景电解质(BGE)组成均使用成年健康志愿者提供的尿液样本进行了优化,并通过信噪比(SNR)和TMAO的峰形进行了评估。优化后的BGE组成为浓度为0.10 mol L的甲酸,SHL组成为70:30的甲醇:水,含有0.05%(v/v)的甲酸,流速为5 μL min。TMAO、左旋肉碱和肌酐的检测限分别为0.76、0.54和303 μmol L。定量限分别为2.5、1.8和1000 μmol L。通过方差分析评估线性,R值在0.993至0.997之间。在三个浓度水平上评估了精密度和准确度。日内精密度评估的变异系数(CV)为1%至21%,日间精密度评估的变异系数为2%至16%。回收率在75%至116%之间。与健康个体相比,对梗死患者尿液中的TMAO和左旋肉碱进行定量分析表明,TMAO增加了2.2倍,左旋肉碱增加了7.0倍。这些结果表明,该方法在心血管疾病等其他疾病的靶向代谢组学研究中,对于评估尿液中TMAO和左旋肉碱以及一组候选代谢物具有潜在的适用性。